logo

For the Inventor, By the Inventor

Taipei, Taiwan

Senhwa Biosciences, Inc.


USPTO Granted Patents = 12


Trademarks = 1

Forward Citations = 35

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal John Soong (5 out of 6 patents)

silverMedal David M Ryckman (4 out of 11 patents)

bronzeMedal Fabrice Pierre (4 out of 21 patents)

4.  Mustapha Haddach (3 out of 34 patents)

5.  Joe Anh Tran (2 out of 12 patents)

6.  Suchitra Ravula (2 out of 13 patents)

7.  Nicholas Brian Raffaele (2 out of 12 patents)

8.  Hshiou-ting Liu (2 out of 8 patents)

9.  Collin F Regan (2 out of 2 patents)

10.  Michael Schwaebe (2 out of 19 patents)

11.  Jeffrey Paul Whitten (2 out of 68 patents)

12.  Iching G Yu (1 out of 3 patents)

13.  Peter C Chua (1 out of 8 patents)

14.  Levan Darjania (1 out of 2 patents)

15.  Johnny Yasuo Nagasawa (1 out of 27 patents)


12 patents:

1. 12673062 - Combination therapy of tetracyclic quinolone analogs for treating cancer (2026-07-07),
2. 12116363 - Combinations for immune-modulation in cancer treatment (2024-10-15),
3. 11696911 - Antiviral compounds and method for treating RNA viral infection, particularly COVID-19 (2023-07-11),
4. 11524012 - Quinolone analogs and their salts, compositions, and method for their use (2022-12-13),
5. 11229654 - Combination therapy of tetracyclic quinolone analogs for treating cancer (2022-01-25),
6. 10857156 - Combination therapy of tetracyclic quinolone analogs for treating cancer (2020-12-08),
7. 9957282 - Crystalline forms of quinolone analogs and their salts (2018-05-01),
8. 9303033 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors (2016-04-05),
9. 9062043 - Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators (2015-06-23),
10. 8853235 - Polymorphs and salts of a kinase inhibitor (2014-10-07),
11. 8853234 - Quinolone analogs and methods related thereto (2014-10-07),
12. 8575177 - Pyrazolopyrimidines and related heterocycles as CK2 inhibitors (2013-11-05),
Company Overview
Senhwa Biosciences, Inc. is a biotechnology company based in Taipei, Taiwan, focused on developing innovative therapies for cancer and viral diseases. The company specializes in the research and development of small molecule drugs, particularly those targeting specific pathways involved in tumor growth and viral replication. With a commitment to advancing healthcare solutions, Senhwa aims to address unmet medical needs through its proprietary technologies and collaborative efforts in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Senhwa Biosciences, Inc. USPTO Patent Assignee Logo
12 Patents

#334 in Taipei

#1,245 in Taiwan

#48,209 in the World

Taipei, TW
Taipei, Taiwan

Senhwa Biosciences, Inc.

Forward Citations = 35

16 inventors:

goldMedal John Soong (5 out of 6 patents)

silverMedal David M Ryckman (4 out of 11 patents)

bronzeMedal Fabrice Pierre (4 out of 21 patents)

4.  Mustapha Haddach (3 out of 34 patents)

5.  Joe Anh Tran (2 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Senhwa Biosciences, Inc.. Retrieved from https://idiyas.com/company/senhwa-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…